CNTB
Price
$2.21
Change
-$0.14 (-5.96%)
Updated
Jul 25 closing price
Capitalization
123.35M
INKT
Price
$18.56
Change
-$0.44 (-2.32%)
Updated
Jul 25 closing price
Capitalization
73.97M
Interact to see
Advertisement

CNTB vs INKT

Header iconCNTB vs INKT Comparison
Open Charts CNTB vs INKTBanner chart's image
Connect Biopharma Holdings
Price$2.21
Change-$0.14 (-5.96%)
Volume$122.67K
Capitalization123.35M
MiNK Therapeutics
Price$18.56
Change-$0.44 (-2.32%)
Volume$125K
Capitalization73.97M
CNTB vs INKT Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. INKT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and INKT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CNTB: $2.21 vs. INKT: $18.56)
Brand notoriety: CNTB and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 76% vs. INKT: 10%
Market capitalization -- CNTB: $123.35M vs. INKT: $73.97M
CNTB [@Biotechnology] is valued at $123.35M. INKT’s [@Biotechnology] market capitalization is $73.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTB is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 3 TA indicator(s) are bullish while INKT’s TA Score has 6 bullish TA indicator(s).

  • CNTB’s TA Score: 3 bullish, 4 bearish.
  • INKT’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, INKT is a better buy in the short-term than CNTB.

Price Growth

CNTB (@Biotechnology) experienced а +28.49% price change this week, while INKT (@Biotechnology) price change was -8.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTB($123M) has a higher market cap than INKT($74M). INKT YTD gains are higher at: 166.322 vs. CNTB (60.145). INKT has higher annual earnings (EBITDA): -9.14M vs. CNTB (-20.6M). CNTB has more cash in the bank: 84M vs. INKT (3.24M). CNTB has less debt than INKT: CNTB (940K) vs INKT (5.12M). CNTB has higher revenues than INKT: CNTB (26M) vs INKT (0).
CNTBINKTCNTB / INKT
Capitalization123M74M166%
EBITDA-20.6M-9.14M225%
Gain YTD60.145166.32236%
P/E RatioN/AN/A-
Revenue26M0-
Total Cash84M3.24M2,597%
Total Debt940K5.12M18%
TECHNICAL ANALYSIS
Technical Analysis
CNTBINKT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 19 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend about 1 month ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUIFF0.09N/A
N/A
Superior Mining International Corp.
APPEF0.75N/A
N/A
Appen Ltd.
ZEOOF9.35N/A
N/A
Zeon Corp.
IPSEY32.42-0.58
-1.75%
Ipsen S.A.
FDMIF2.53-0.15
-5.67%
FOUNDERS METALS INC.

CNTB and

Correlation & Price change

A.I.dvisor tells us that CNTB and INKT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTB and INKT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
-5.96%
INKT - CNTB
28%
Poorly correlated
-2.32%
ABCZF - CNTB
28%
Poorly correlated
N/A
THAR - CNTB
25%
Poorly correlated
-2.35%
VERA - CNTB
23%
Poorly correlated
-0.32%
ALDX - CNTB
23%
Poorly correlated
-4.96%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-2.32%
RAIN - INKT
44%
Loosely correlated
+0.44%
LPTX - INKT
42%
Loosely correlated
-1.56%
PHVS - INKT
34%
Loosely correlated
+2.84%
HYPD - INKT
34%
Loosely correlated
-5.75%
CADL - INKT
34%
Loosely correlated
+0.29%
More